Slump In Generic Submissions Helps US FDA Draw Nearly Even With Approvals

Agency Publishes Data For First Half Of Current Fiscal Year

ANDA approval rates have remained steady, while submission rates dropped compared to prior years.

Generic drugs
The monthly approval rate would be the second-best of the GDUFA era if sustained through the second half of FY 2021 • Source: Alamy

More from Generics

More from Products